beta-hydroxyisovalerylshikonin has been researched along with tyrosine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Nakajo, S; Nakaya, K; Xu, Y | 1 |
1 other study(ies) available for beta-hydroxyisovalerylshikonin and tyrosine
Article | Year |
---|---|
Synergistic inhibitory effects of transplatin and beta-hydroxyisovalerylshikon on carcinoma A431 cells involve epidermal growth factor receptor.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Synergism; ErbB Receptors; Humans; Naphthoquinones; Oncogene Protein pp60(v-src); Phosphorylation; Tumor Cells, Cultured; Tyrosine | 2002 |